These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 37332750)

  • 21. Plant-Derived Compounds and Extracts as Modulators of Plasmin Activity-A Review.
    Kolodziejczyk-Czepas J; Czepas J
    Molecules; 2023 Feb; 28(4):. PubMed ID: 36838662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH; Schindler AE; Endrikat J; Düsterberg B
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
    Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrin-associated plasminogen activation in alpha 2-plasmin inhibitor deficiency.
    Aoki N; Sakata Y; Ichinose A
    Blood; 1983 Nov; 62(5):1118-22. PubMed ID: 6626743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
    Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
    Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.
    Carr ME; Alving BM
    Blood Coagul Fibrinolysis; 1995 Sep; 6(6):567-73. PubMed ID: 7578900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacology of fibrinolysis.
    Haire WD
    Chest; 1992 Apr; 101(4 Suppl):91S-97S. PubMed ID: 1555484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen: an enigmatic zymogen.
    Keragala CB; Medcalf RL
    Blood; 2021 May; 137(21):2881-2889. PubMed ID: 33735914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The fibrinolytic system-more than fibrinolysis?
    Draxler DF; Medcalf RL
    Transfus Med Rev; 2015 Apr; 29(2):102-9. PubMed ID: 25576010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment.
    Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K
    Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolysis at the fluid-solid interface of thrombi.
    Kolev K; Longstaff C; Machovich R
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):341-55. PubMed ID: 16250865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasminogen activation by tissue plasminogen activator on fibrin clots with different surface structures].
    Savchuk AN
    Ukr Biokhim Zh (1999); 2001; 73(3):87-90. PubMed ID: 12035559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma.
    Cruz DBD; Helms J; Aquino LR; Stiel L; Cougourdan L; Broussard C; Chafey P; Riès-Kautt M; Meziani F; Toti F; Gaussem P; Anglés-Cano E
    FASEB J; 2019 Dec; 33(12):14270-14280. PubMed ID: 31682515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microscale structural changes of individual fibrin fibers during fibrinolysis.
    Lynch SR; Laverty SM; Bannish BE; Hudson NE
    Acta Biomater; 2022 Mar; 141():114-122. PubMed ID: 35007782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrin-specific thrombolytic agents.
    Collen D
    Klin Wochenschr; 1988; 66 Suppl 12():15-23. PubMed ID: 3126344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fibrin degradation products on fibrinolytic process.
    Yatsenko TA; Rybachuk VM; Yusova OI; Kharchenko SM; Grinenko TV
    Ukr Biochem J; 2016; 88(2):16-24. PubMed ID: 29227597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.